JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Griffin, D. D.
Right arrow Articles by the National Rotavirus Strain Surveillance System Collaborating Laboratories,
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Griffin, D. D.
Right arrow Articles by the National Rotavirus Strain Surveillance System Collaborating Laboratories,

Journal of Clinical Microbiology, July 2000, p. 2784-2787, Vol. 38, No. 7
0095-1137/00/$04.00+0

Surveillance of Rotavirus Strains in the United States: Identification of Unusual Strains

D. D. Griffin,* C. D. Kirkwood, U. D. Parashar, P. A. Woods, J. S. Bresee, R. I. Glass, J. R. Gentsch, and the National Rotavirus Strain Surveillance System Collaborating Laboratoriesdagger

Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

Received 30 November 1999/Returned for modification 10 March 2000/Accepted 2 May 2000

Rotavirus strains from 964 fecal specimens collected from children at 11 U.S. hospital laboratories from November 1997 to March 1998 and from samples collected at 12 laboratories from November 1998 to March 1999 were typed for G and P proteins. Serotype G1 was the predominant serotype in 1997-1998 (88%), followed by G2 (6.2%), G9 (3.3%), and G3 (1.5%). This pattern was similar to that seen in 1998-1999: G1 (79%), G2 (15%), G9 (3.0%), G4 (1.6%), and G3 (0.3%). Novel P[9] strains were identified in both seasons, and analysis of a 364-nucleotide fragment from gene segment 4 of one of the strains demonstrated 97.3% nucleotide identity with the prototype P3[9],G3 strain, AU1, isolated in Japan. This is the first report of a human AU1-like strain in the United States. These results reinforce our initial findings that serotype G9 persists in the United States but has not become a predominant strain and that the common serotypes G1 to G4 account for almost 90% of strains in circulation. Other uncommon strains exist in the United States but may have been overlooked before because of their low prevalence and the use of inadequate diagnostic tools.

* Corresponding author. Mailing address: Viral Gastroenteritis Section MS G04, Respiratory and Enteric Viruses Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., NE, Atlanta, GA 30333. Phone: (404) 639-3628. Fax: (404) 639-3645. E-mail: dkg2{at}cdc.gov.

dagger Participants in the National Rotavirus Strain Surveillance System include Rebecca Nelson, Arkansas Children's Hospital, Little Rock; Michelle Hartin, Children's Hospital of San Diego, San Diego, Calif.; Christine Robinson, Children's Hospital of Denver, Denver, Colo.; Yolanda Arcilla, Medical Center of Delaware, Newark; Gayle Bloom, Clarian Health Partners, Indianapolis, Ind.; David Abel, Children's Mercy Hospital of Kansas City, Kansas City, Mo.; Gary Leonardi, Nassau County Medical Center, East Meadow, N.Y.; Paul A. Yam, Children's Memorial Hospital of Omaha, Omaha, Nebr.; DeLores Aiazzi, Washoe Medical Center of Reno, Reno, Nev.; H. Fred Clark, Children's Hospital of Philadelphia, Philadelphia, Pa.; Pam Zapalec, Driscoll Foundation Children's Hospital of Corpus Christi, Corpus Christi, Tex.; Charles Ash, Egleston Children's Hospital, Atlanta, Ga.; and Kathy Dugaw, Children's Hospital and Regional Medical Center, Seattle, Wash.

Journal of Clinical Microbiology, July 2000, p. 2784-2787, Vol. 38, No. 7
0095-1137/00/$04.00+0


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2000 by the American Society for Microbiology. All rights reserved.